Anticoagulation in non-valvular atrial fibrillation: Current landscape.

30 August 2020 (12:45 - 13:00)

Organised by:

Video

Sign in to view the resources

About the speaker

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)

3 More presentations in this session

Presentation thumbnail

Improving outcomes for non-valvular atrial fibrillation patients with acute coronary syndrome and/or requiring percutaneous coronary intervention.

Professor R. Lopes (Durham, US)

Presentation thumbnail

Improving patient outcomes through atrial fibrillation screening: Current situation and future directions.

Doctor E. Svennberg (Stockholm, SE)

Presentation thumbnail

Questions and Answers: Are we closing knowledge and practice gaps?

Professor S. Hohnloser (Frankfurt, DE) Professor R. Lopes (Durham, US) Doctor E. Svennberg (Stockholm, SE)

Access the full session

Session thumbnail

Anticoagulation management in non-valvular atrial fibrillation: optimising patient outcomes

The Event

ESC Congress 2020

30 August 2020 12:45 CET

You may be interested in

Webinar

Are NOACs already outdated? New trends in anticoagulation therapy

12 December 2022

Congress Presentation

Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

27 August 2021

Congress Session

Update on antiarrhythmic therapy

31 March 2025

Congress Presentation

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients with differential duration of treatment: an analysis of the ARISTOPHANES study

2 September 2019

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources